Skip to content

Medicine Man Technologies, Inc.: 10-Q filed 2018-11-08

What Medicine Man Technologies, Inc. reported in its quarterly report filed 2018-11-08 (fiscal Q3 2018): 37 published measures, 96 facts as tagged in accession 0001683168-18-003304.

This filing

Form
10-Q (quarterly report)
Filed
2018-11-08
Fiscal period
fiscal Q3 2018
Accession
0001683168-18-003304 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Medicine Man Technologies, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2018-09-3021,007,420USD
At 2017-12-3111,132,363USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2018-09-30273,044USD
At 2017-12-31393,203USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2018-09-3020,734,376USD
At 2017-12-3110,739,160USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2018-09-30529,674USD
At 2017-12-31748,715USD
At 2017-09-30927,884USD
At 2016-12-31351,524USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2018-07-01 to 2018-09-304,950,679USD92
2018-01-01 to 2018-09-305,157,717USD273
2017-07-01 to 2017-09-30-485,627USD92
2017-01-01 to 2017-09-30-4,868,859USD273

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2018-01-01 to 2018-09-304,083,892USD273
2017-01-01 to 2017-09-30-637,052USD273

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2018-07-01 to 2018-09-304,647,163USD92
2018-01-01 to 2018-09-307,301,243USD273
2017-07-01 to 2017-09-30928,264USD92
2017-01-01 to 2017-09-302,351,752USD273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2018-01-01 to 2018-09-301,000,000USD273
2017-01-01 to 2017-09-301,238,435USD273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2018-01-01 to 2018-09-30-5,302,933USD273
2017-01-01 to 2017-09-30-5,023USD273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2018-09-30-1,631,933USD
At 2017-12-31-6,789,650USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2018-09-3084,493USD
At 2017-12-31150,047USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2018-07-01 to 2018-09-30837,500USD92
2018-01-01 to 2018-09-30837,500USD273
2017-07-01 to 2017-09-30164,000USD92
2017-01-01 to 2017-09-304,644,318USD273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2018-07-01 to 2018-09-302,345,007USD92
2018-01-01 to 2018-09-302,541,484USD273
2017-07-01 to 2017-09-30-319,746USD92
2017-01-01 to 2017-09-30-4,735,132USD273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2018-09-303,248,639USD
At 2017-12-311,575,798USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2018-09-30273,044USD
At 2017-12-31334,923USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2018-09-30172,360USD
At 2017-12-31123,251USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

PeriodValueUnitDays
At 2018-09-3012,304,306USD
At 2017-12-319,304,306USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2018-09-3082,825USD
At 2017-12-3187,712USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2018-09-301,009,170USD
At 2017-12-31461,343USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2018-07-01 to 2018-09-301,842,876USD92
2018-01-01 to 2018-09-303,546,565USD273
2017-07-01 to 2017-09-30950,825USD92
2017-01-01 to 2017-09-306,352,539USD273

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2018-09-30441,960USD
At 2017-12-31106,091USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2018-07-01 to 2018-09-304,187,883USD92
2018-01-01 to 2018-09-306,088,049USD273
2017-07-01 to 2017-09-30631,079USD92
2017-01-01 to 2017-09-301,617,407USD273

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2018-07-01 to 2018-09-30459,280USD92
2018-01-01 to 2018-09-301,213,194USD273
2017-07-01 to 2017-09-30297,185USD92
2017-01-01 to 2017-09-30734,345USD273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2018-09-3027,578,310shares
At 2017-12-3122,991,137shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2018-09-3020,283,174USD
At 2017-12-3113,997,441USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2018-09-300USD
At 2017-12-310USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2018-09-30215,898USD
At 2017-12-31232,085USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2018-09-30131,405USD
At 2017-12-3182,038USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2018-09-3026,317USD
At 2017-12-3114,500USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2018-09-3047,684USD
At 2017-12-310USD

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2018-07-01 to 2018-09-304,950,679USD92
2018-01-01 to 2018-09-305,157,717USD273
2017-07-01 to 2017-09-30-485,627USD92
2017-01-01 to 2017-09-30-4,868,859USD273

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2018-07-01 to 2018-09-30170,117USD92
2018-01-01 to 2018-09-30417,467USD273
2017-07-01 to 2017-09-30331,764USD92
2017-01-01 to 2017-09-30735,018USD273

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2018-01-01 to 2018-09-3056,275USD273
2017-01-01 to 2017-09-3040,659USD273

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2018-01-01 to 2018-09-3054,253USD273
2017-01-01 to 2017-09-3043,650USD273

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2018-07-01 to 2018-09-302,605,672USD92
2018-01-01 to 2018-09-302,616,233USD273
2017-07-01 to 2017-09-30-165,881USD92
2017-01-01 to 2017-09-30-133,727USD273

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2018-01-01 to 2018-09-301,566,811USD273
2017-01-01 to 2017-09-30373,902USD273

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2018-01-01 to 2018-09-30335,869USD273
2017-01-01 to 2017-09-3087,685USD273

Inspect the source

Entity
Medicine Man Technologies, Inc. / CIK 0001622879
Captured
SEC response SHA-256
1261bd7a9caa81b103d72d0d0ab2acc4054c1fb2aa448834ecbc9bb252b5bd72

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001622879.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))